Clovis oncology inc

Major-Pharmaceuticals

CLVS


5500 Flatiron Parkway
Boulder , CO 80301

Executive/
Director

Links

Price

  • Last Close
  • $ 0.2
    $ -0.02 -9.09 %
    Dec 9, 2022
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 2,422,200
  • Market Cap Full
  • $ 29M
  • Shares Outstanding
  • 145M
    Nov 4, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -45.1% 43.3% -22.4% 38.2% -5% 46.3% -14% - - -
Q2 -28.5% 47.1% -9.5% -38.4% 4% -17.4% -22.8% - - -
Q3 162.8% -12% -34.9% -74.2% 8% -23.1% -33.9% - - -
Q4 23.2% -15.4% -38.4% 168.5% -17.7% -39.2% -83.2% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -38%27%53%-74%-42%-54%-44%-93%0%0%0%

Earnings

2016 2017 2018 2019 2020 2021
Q1 2.17 1.33 -1.54 -1.63 -1.39 -0.64
Q2 2.07 1.29 -1.94 -2.27 -1.15 -0.61
Q3 1.70 1.24 -1.71 -1.72 -0.89 -0.56
Q4 1.83 1.27 -1.88 -1.81 -0.95 -
A 7.8 5.1 -7.1 -7.4 -4.4 -2.3

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - 52.9 73.4 104.5 142.2
Jun 52.5 53 76.9 104.6 143.9
Sep 52.6 54.7 88.2 118.4 144.5
Dec 52.7 54.8 88.3 130 145

Financial Ratios

20202019201820172016
Asset Management
Inventory / Stock Turnover 1.3 1.3 0.8 0.4 -
Fixed Asset Turnover 0.6 0.5 0.3 0.5 -
Total Asset Turnover 0.3 0.2 0.1 0.1 -
Leverage
Debt Ratio 1.8 1.9 1 0.5 1
Debt – Equity Ratio -3.4 -3.9 3.9 0.8 -77.4
Interest Coverage -4.5 -15.9 -9.8 -2.2 15.8
Equity multiplier -1.9 -1.7 2 0.3 -23.4